BSR guidelines

2012



Top Ten Quality Standards for RA
January 2012

2011



BSR Statement on Vaccination in Adult Patients with Rheumatic Diseases
November 2011

BSR/BSPAR Consensus statement on biologics in adults with JIA
June 2011

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
May 2011

2010



Principles for biologic prescribing
December 2010

RA guidelines on safety of anti-TNF therapies
September 2010

Management of giant cell arteritis
April 2010

RA guidelines on eligibility criteria for the first biological therapy
March 2010

2009



Quick reference guideline for monitoring of disease-modifying anti-rheumatic drug (DMARD) therapy

To accompany Disease-modifying anti-rheumatic drug (DMARD) therapy guideline - April 2008
November 2009

Management of polymyalgia rheumatica
BSR and BHPR guideline
November 2009

Management of rheumatoid arthritis (after first 2 years )
BSR and BHPR guideline
January 2009

2008



Disease-modifying anti-rheumatic drug (DMARD) therapy
BSR and BHPR guideline in consultation with the British Association of Dermatologists
April 2008

Appendix - Metoject
August 2010

2007

Management of adults with ANCA associated vasculitis
BSR and BHPR guideline
October 2007

Management of gout
BSR and BHPR guideline
June 2007

2006


Management of rheumatoid arthritis (first 2 years)
BSR and BHPR guideline
July 2006

Management of hot swollen joints in adults
BSR & BHPR, BOA, RCGP and BSAC guideline
July 2006
Hot Swollen Joint Interactive Guideline Powerpoint

2005


Anti-TNF alpha therapy in psoriatic arthritis
BSR guideline
February 2005

2004


Prescribing TNF blockers in adults with rheumatoid arthritis
BSR guideline
July 2004 (update of previous guidelines of April 2001)

Standards of care for persons with rheumatoid arthritis
BSR guideline
July 2004

Prescribing TNF alpha blockers in adults with ankylosing spondylitis
BSR guideline
July 2004